BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/20/2025 8:39:03 AM | Browse: 111 | Download: 475
 |
Received |
|
2024-09-10 06:04 |
|
Peer-Review Started |
|
2024-09-19 01:11 |
|
First Decision by Editorial Office Director |
|
2024-12-05 10:17 |
|
Return for Revision |
|
2024-12-05 10:17 |
|
Revised |
|
2024-12-09 07:32 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-12-17 02:43 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-12-17 08:57 |
|
Articles in Press |
|
2024-12-17 08:57 |
|
Edit the Manuscript by Language Editor |
|
2024-12-30 00:34 |
|
Typeset the Manuscript |
|
2025-02-11 01:43 |
|
Publish the Manuscript Online |
|
2025-02-20 08:39 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Sarcopenia and metabolic dysfunction-associated steatotic liver disease: The role of exercise-related biomarkers
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Marwan S Al-Nimer |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Marwan S Al-Nimer, MD, PhD, Department of Therapeutics and Clinical Pharmacology, College of Medicine, University of Diyala, University Street, Baqubah 32001, Iraq. marwanalnimer@yahoo.com |
| Key Words |
Sarcopenia; Metabolic dysfunction associate-steatotic liver disease; Physical inactivity; Myokines; Irisin |
| Core Tip |
Sarcopenia and metabolic dysfunction-associated steatotic liver disease (MDASLD) share similar physical inactivity, risk factors, and pathophysiology. In both conditions, physical inactivity is a remarkable clinical finding. Determination of irisin in the biological fluids serves as a good marker for physical activity as it elevates during muscle contraction. In sarcopenia, serum irisin declined, while in MDASLD it increased. Therefore, a transition of serum irisin from higher to lower levels in MDASLD could indicate the occurrence of sarcopenia. |
| Publish Date |
2025-02-20 08:39 |
| Citation |
Al-Nimer MS. Sarcopenia and metabolic dysfunction-associated steatotic liver disease: The role of exercise-related biomarkers. World J Hepatol 2025; 17(2): 101165 |
| URL |
https://www.wjgnet.com/1948-5182/full/v17/i2/101165.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v17.i2.101165 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
